[Anti-inflammatory action of N-(2,6-dichlorophenyl)-o-aminophenylacetic acid, its sodium salt, N-(2,6-dichlorophenyl)-anthranilic acid and its sodium salt. 1. On acute inflammation].
D000208:Acute Disease; D000818:Animals; D000893:Anti-Inflammatory Agents; D002199:Capillary Permeability / Q000187:drug effects; D004487:Edema / Q000188:drug therapy; D004573:Electrolytes / Q000378:metabolism; D004890:Erythema / Q000517:prevention & control; D005260:Female; D005439:Flufenamic Acid / Q000494:pharmacology; D006168:Guinea Pigs; D006461:Hemolysis / Q000187:drug effects; D066298:In Vitro Techniques; D007213:Indomethacin / Q000494:pharmacology; D007249:Inflammation / Q000188:drug therapy; D008528:Mefenamic Acid / Q000494:pharmacology; D009119:Muscle Contraction / Q000187:drug effects; D010648:Phenylacetates / Q000494:pharmacology*; D010653:Phenylbutazone / Q000494:pharmacology; D011239:Prednisolone / Q000494:pharmacology; D011489:Protein Denaturation / Q000187:drug effects; D051381:Rats; D012709:Serum Albumin; D062367:ortho-Aminobenzoates / Q000494:pharmacology*
D000893:Anti-Inflammatory Agents; D004573:Electrolytes; D010648:Phenylacetates; D012709:Serum Albumin; D062367:ortho-Aminobenzoates; D008528:Mefenamic Acid; D005439:Flufenamic Acid; D011239:Prednisolone; D010653:Phenylbutazone; D007213:Indomethacin